Psychiatry and Neurology, Neurology · Beverly Hills, CA
NPI
1568894988
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
8530 Wilshire Blvd Ste 250
Beverly Hills, CA, 90211
Phone (310) 933-4590
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
18,018 services
Medicare patients, 2024
1,816
Average age 71
Drug cost, 2024
$16.3M
19,403 prescriptions
Company payments, 2025
$12K
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan J Eskenazi was code 99233 (hospital e&m - subsequent), 4,504 times for 418 patients. In total Jonathan J Eskenazi billed 18,018 services in 44 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 4,504 | 418 | $95.91 | $432K |
| 99214 Office E&M - Established | Office | 4,424 | 1,399 | $102.02 | $451K |
| 95886 Electrical Nerve Conductivity | Office | 829 | 250 | $83.71 | $69K |
| 96415 Chemotherapy Administration | Office | 754 | 72 | $24.45 | $18K |
| 92547 Vision, Hearing, and Speech Services | Office | 571 | 524 | $9.71 | $5,543 |
| 97110 PT Treatment | Office | 559 | 509 | $24.81 | $14K |
| 99223 Hospital E&M - Initial | Facility | 549 | 401 | $140.33 | $77K |
| 93890 Ultrasound - Nonspecific | Office | 506 | 501 | $199.66 | $101K |
| 93892 Ultrasound - Nonspecific | Office | 506 | 501 | $144.15 | $73K |
| 92540 Vision, Hearing, and Speech Services | Office | 505 | 491 | $89.59 | $45K |
| 95715 Neurologic | Office | 505 | 168 | $749.46 | $378K |
| 92546 Vision, Hearing, and Speech Services | Office | 502 | 461 | $117.34 | $59K |
| 93886 Ultrasound - Nonspecific | Office | 498 | 494 | $191.34 | $95K |
| 99204 Office E&M - New | Office | 492 | 492 | $125.29 | $62K |
| 95819 Neurologic | Office | 454 | 447 | $400.27 | $182K |
By year: 2022 $2.7M for 23,721 services; 2023 $2.9M for 20,348 services; 2024 $2.5M for 18,018 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan J Eskenazi prescribed most often to Medicare patients was Memantine Hcl, with 2,478 prescriptions and refills. In total Jonathan J Eskenazi wrote 19,403 Medicare prescriptions that cost $16.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 2,478 | 2,700 | 619 | $23K |
| Gabapentin Generic | 2,195 | 2,296 | 804 | $9,254 |
| Meclizine Hcl Generic | 1,360 | 1,432 | 498 | $5,614 |
| Sumatriptan Succinate Generic | 994 | 998 | 284 | $6,343 |
| Donepezil Hcl Generic | 935 | 1,220 | 304 | $5,126 |
| Lidocaine Generic | 855 | 901 | 380 | $53K |
| Baclofen Generic | 800 | 909 | 267 | $5,431 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 571 | 771 | 136 | $11K |
| Duloxetine Hcl Generic | 549 | 568 | 185 | $5,795 |
| Topiramate Generic | 527 | 700 | 194 | $2,879 |
| Pregabalin Generic | 443 | 450 | 167 | $5,261 |
| Levetiracetam Generic | 440 | 643 | 128 | $10K |
| Primidone Generic | 394 | 496 | 126 | $3,585 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 363 | 363 | 88 | $8.7M |
| Namzaric Memantine Hcl/Donepezil Hcl | 355 | 377 | 74 | $223K |
Brand drugs: 2,513 claims; generic drugs: 16,842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan J Eskenazi $12K ($12K in general payments such as food, travel and fees) from 40 companies. The largest payer was Noctrix Health, Inc. with $941.
| Company | Payments | Amount |
|---|---|---|
| Noctrix Health, Inc. | 9 | $941 |
| Neurocrine BioSciences, Inc. NBIX | 31 | $902 |
| UCB, Inc. UCB.BR | 28 | $883 |
| SK Life Science, Inc. | 24 | $859 |
| LivaNova USA, Inc. LIVN | 23 | $706 |
| Genentech USA, Inc. ROG.SW | 20 | $644 |
| Vanda Pharmaceuticals Inc. VNDA | 18 | $623 |
| CSL Behring CSL.AX | 22 | $515 |
| Forte Bio-Pharma LLC | 22 | $473 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $441 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.